CA9 and neoplasm: Complete regression of tumor was achieved in 20% of combination-treated mice, while 10% of anti-CAIX CAR-T cells alone treated mice, whereas no anti-tumor effects were observed in LB-100 alone treated mice (Figure 3B–D).